Correlation Between Genovate Biotechnology and AzureWave Technologies

Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and AzureWave Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and AzureWave Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Genovate Biotechnology Co and AzureWave Technologies, you can compare the effects of market volatilities on Genovate Biotechnology and AzureWave Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of AzureWave Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and AzureWave Technologies.

Diversification Opportunities for Genovate Biotechnology and AzureWave Technologies

-0.31

Correlation Coefficient

Genovate Biotechnology  AzureWave Technologies

Very good diversification

The 3 months correlation between Genovate and AzureWave is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and AzureWave Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AzureWave Technologies and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with AzureWave Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AzureWave Technologies has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and AzureWave Technologies go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and AzureWave Technologies

Assuming the 90 days trading horizon Genovate Biotechnology Co is expected to generate 0.63 times more return on investment than AzureWave Technologies. However, Genovate Biotechnology Co is 1.58 times less risky than AzureWave Technologies. It trades about 0.35 of its potential returns per unit of risk. AzureWave Technologies is currently generating about 0.09 per unit of risk. If you would invest  2,070  in Genovate Biotechnology Co on October 22, 2024 and sell it today you would earn a total of  450.00  from holding Genovate Biotechnology Co or generate 21.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.24%
Values	Daily Returns

Genovate Biotechnology Co  vs.  AzureWave Technologies

Genovate Biotechnology

Risk-Adjusted Performance

4 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Genovate Biotechnology Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Genovate Biotechnology may actually be approaching a critical reversion point that can send shares even higher in February 2025.

AzureWave Technologies

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in AzureWave Technologies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, AzureWave Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Genovate Biotechnology and AzureWave Technologies

The main advantage of trading using opposite Genovate Biotechnology and AzureWave Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, AzureWave Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AzureWave Technologies will offset losses from the drop in AzureWave Technologies' long position.

The idea behind Genovate Biotechnology Co and AzureWave Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.